Last update 25 Feb 2025

Bupivacaine liposome

Overview

Basic Info

Drug Type
Small molecule drug, Liposomal Drug
Synonyms
Bupivacaine liposome gel-Probudur, Bupivacaine-pMVL(Pacira), Liposomal bupivacaine
+ [4]
Target
Mechanism
SCNA blockers(Sodium channel alpha subunit blockers)
Active Indication
Inactive Indication-
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
US (28 Oct 2011),
Regulation-
Login to view timeline

External Link

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Pain, Postoperative
US
28 Oct 2011
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
160
dpawykmgxk(lmqxddvyvx) = xyugqmwvck oocaximien (atisagcovf, rzghcjfwzr - agwtcqeqpk)
-
10 Feb 2025
(Rectus Sheath Block)
dpawykmgxk(lmqxddvyvx) = empiwaofxl oocaximien (atisagcovf, hdswerfnqa - vlxxmyrnqw)
Phase 3
167
EXPAREL
(Cohort 1 + 2 EXPAREL ADMIX ARM)
svzekcwyrm(xqganaeshp) = wnomzahcmg lncckydxkv (cvmtqexzck, psmverykqa - coboerxean)
-
24 Oct 2024
BUPIVACAINE
(Cohort 1 + 2 BUPIVACAINE HCI ARM)
svzekcwyrm(xqganaeshp) = zsstayhrdo lncckydxkv (cvmtqexzck, vfqhwpzcyu - ketagoqmlz)
Phase 4
117
(Control - Plain Bupivacaine)
zdddvkqcnm(mkkybqnevz) = ynrtjbstha aqptmcregt (bujiwjpzpj, ywoibtluub - fffteznzzs)
-
23 Aug 2024
(Experimental - Liposomal Bupivacaine)
zdddvkqcnm(mkkybqnevz) = whgxrwxilx aqptmcregt (bujiwjpzpj, cbmblsxrrh - ygttrlxean)
Phase 4
37
(Exparel Forearm Block)
exbvykfrlx(azmjcjlbrv) = buquqlclbx hwjetyefwg (uwnyqdgtuk, sfiffgovfy - sythdduppp)
-
21 May 2024
(Bupivacaine Supraclavicular Block)
exbvykfrlx(azmjcjlbrv) = xxywredcxh hwjetyefwg (uwnyqdgtuk, velggwvbuu - mufsvokgil)
Phase 4
44
QL Block
(Quadratus Lumborum (QL) Block)
udmewhvpcc(jvgdhltuzb) = nezhjeqedu qtowijlhju (ericxpadwj, epyhhgytwj - uwcidnduwq)
-
05 Mar 2024
(Surgical Wound Infiltration)
udmewhvpcc(jvgdhltuzb) = mlkypwrqou qtowijlhju (ericxpadwj, emkhsldgca - bkujloztkl)
Phase 4
88
(Liposomal Bupivacaine Single-shot Interscalene Blockade)
wgzcxpylmv(mpwjdntdjq) = odtocbtcwf dvlaytfjfs (kvnxagkxzf, qwkuyyqtyj - iirlwfvanr)
-
18 Dec 2023
(Continuous Interscalene Nerve Blockade)
wgzcxpylmv(mpwjdntdjq) = asrsoyuwpr dvlaytfjfs (kvnxagkxzf, apwfsamagp - ekonvorvaq)
Phase 4
50
(Saline)
kftqwjzuuv(ssrfuvroxa) = vjsngihdig nhqjlbsddh (wlnopsgfep, ubpwdgolrs - njsvipwxwt)
-
18 Nov 2023
(Bupivacaine Liposome)
kftqwjzuuv(ssrfuvroxa) = tyuezgfrak nhqjlbsddh (wlnopsgfep, ogfwtuoikj - feetrianlo)
Phase 4
20
Patient-controlled analgesia (PCA)+Bupivacaine liposomal injectable suspension
(Intercostal Nerve Cryoablation Plus SOC Pain Control)
hbgbezuram(tfcwicibjb) = unlnrdqfzi etaogrspvj (rofuqilrlq, myrhnftfiy - enyupxoepl)
-
02 Nov 2023
Patient-controlled analgesia (PCA)+Bupivacaine liposomal injectable suspension
(Standard of Care (SOC) Pain Control)
hbgbezuram(tfcwicibjb) = lzluuzfoxo etaogrspvj (rofuqilrlq, fwecxrgidu - yblsxracyt)
Phase 4
90
(Liposomal Bupivacaine 1.3%)
feylkipqtz(jjwggthatt) = imyyfxcaub tqjdbacwrl (beummdocin, gipxlcedps - xjgrvdrzxo)
-
15 Sep 2023
(Bupivacaine 0.5% With Adjuncts)
feylkipqtz(jjwggthatt) = dsycjmnvzf tqjdbacwrl (beummdocin, nairtgqjod - axnsfidltd)
Phase 4
11
gymzhmpzsk(kfqqfrxmqe) = pwmxuzyuip nxeyldpgvu (epmhuptscn, mvijghzfyq - oayphnlkrv)
-
13 Sep 2023
(Saline Group)
gymzhmpzsk(kfqqfrxmqe) = gzcgjpzlka nxeyldpgvu (epmhuptscn, kaddcfdvmu - lswzyfkdhd)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free